Search

Your search keyword '"Carlotta Buzzoni"' showing total 2 results
Start Over Author "Carlotta Buzzoni" Publisher bmc
2 results on '"Carlotta Buzzoni"'

1. Characteristics of people living in Italy after a cancer diagnosis in 2010 and projections to 2020

Author

Stefano Guzzinati, Saverio Virdone, Roberta De Angelis, Chiara Panato, Carlotta Buzzoni, Riccardo Capocaccia, Silvia Francisci, Anna Gigli, Manuel Zorzi, Giovanna Tagliabue, Diego Serraino, Fabio Falcini, Claudia Casella, Antonio Giampiero Russo, Fabrizio Stracci, Bianca Caruso, Maria Michiara, Anna Luisa Caiazzo, Marine Castaing, Stefano Ferretti, Lucia Mangone, Giuseppa Rudisi, Flavio Sensi, Guido Mazzoleni, Fabio Pannozzo, Rosario Tumino, Mario Fusco, Paolo Ricci, Gemma Gola, Adriano Giacomin, Francesco Tisano, Giuseppa Candela, Anna Clara Fanetti, Filomena Pala, Antonella Sutera Sardo, Massimo Rugge, Laura Botta, and Luigino Dal Maso

Subjects
Cancer prevalence, Projections, Survivors, Italy, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
Abstract

Abstract Background Estimates of cancer prevalence are widely based on limited duration, often including patients living after a cancer diagnosis made in the previous 5 years and less frequently on complete prevalence (i.e., including all patients regardless of the time elapsed since diagnosis). This study aims to provide estimates of complete cancer prevalence in Italy by sex, age, and time since diagnosis for all cancers combined, and for selected cancer types. Projections were made up to 2020, overall and by time since diagnosis. Methods Data were from 27 Italian population-based cancer registries, covering 32% of the Italian population, able to provide at least 7 years of registration as of December 2009 and follow-up of vital status as of December 2013. The data were used to compute the limited-duration prevalence, in order to estimate the complete prevalence by means of the COMPREV software. Results In 2010, 2,637,975 persons were estimated to live in Italy after a cancer diagnosis, 1.2 million men and 1.4 million women, or 4.6% of the Italian population. A quarter of male prevalent cases had prostate cancer (n = 305,044), while 42% of prevalent women had breast cancer (n = 604,841). More than 1.5 million people (2.7% of Italians) were alive since 5 or more years after diagnosis and 20% since ≥15 years. It is projected that, in 2020 in Italy, there will be 3.6 million prevalent cancer cases (+ 37% vs 2010). The largest 10-year increases are foreseen for prostate (+ 85%) and for thyroid cancers (+ 79%), and for long-term survivors diagnosed since 20 or more years (+ 45%). Among the population aged ≥75 years, 22% will have had a previous cancer diagnosis. Conclusions The number of persons living after a cancer diagnosis is estimated to rise of approximately 3% per year in Italy. The availability of detailed estimates and projections of the complete prevalence are intended to help the implementation of guidelines aimed to enhance the long-term follow-up of cancer survivors and to contribute their rehabilitation needs.

Published
2018
Full Text
View/download PDF

2. Characteristics of people living in Italy after a cancer diagnosis in 2010 and projections to 2020

Author

Paolo Ricci, Anna Luisa Caiazzo, Stefano Guzzinati, Flavio Sensi, Massimo Rugge, F Tisano, Anna Gigli, Rosario Tumino, Diego Serraino, Giuseppa Candela, Fabrizio Stracci, Giovanna Tagliabue, Lucia Mangone, Guido Mazzoleni, Antonio Russo, Stefano Ferretti, Adriano Giacomin, G Gola, F Pala, Marine Castaing, Fabio Pannozzo, Roberta De Angelis, Maria Michiara, Saverio Virdone, Claudia Casella, Laura Botta, Luigino Dal Maso, Carlotta Buzzoni, Silvia Francisci, A.C. Fanetti, Giuseppa Rudisi, Fabio Falcini, Antonella Sutera Sardo, Mario Fusco, Chiara Panato, Bianca Caruso, Manuel Zorzi, and Riccardo Capocaccia

Subjects
Male, Cancer Research, Cancer prevalence, Italy, Projections, Survivors, Adolescent, Adult, Age Distribution, Aged, Aged, 80 and over, Child, Child, Preschool, Female, Forecasting, Humans, Infant, Infant, Newborn, Middle Aged, Neoplasms, Prevalence, Registries, Sex Distribution, Young Adult, Oncology, Genetics, Prostate cancer, 0302 clinical medicine, Epidemiology of cancer, 80 and over, 030212 general & internal medicine, Young adult, Thyroid cancer, education.field_of_study, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, 3. Good health, 030220 oncology & carcinogenesis, Research Article, Population, Socio-culturale, lcsh:RC254-282, 03 medical and health sciences, Breast cancer, medicine, Preschool, education, business.industry, Cancer, Newborn, medicine.disease, Cancer registry, business, Demography
Abstract

Background Estimates of cancer prevalence are widely based on limited duration, often including patients living after a cancer diagnosis made in the previous 5 years and less frequently on complete prevalence (i.e., including all patients regardless of the time elapsed since diagnosis). This study aims to provide estimates of complete cancer prevalence in Italy by sex, age, and time since diagnosis for all cancers combined, and for selected cancer types. Projections were made up to 2020, overall and by time since diagnosis. Methods Data were from 27 Italian population-based cancer registries, covering 32% of the Italian population, able to provide at least 7 years of registration as of December 2009 and follow-up of vital status as of December 2013. The data were used to compute the limited-duration prevalence, in order to estimate the complete prevalence by means of the COMPREV software. Results In 2010, 2,637,975 persons were estimated to live in Italy after a cancer diagnosis, 1.2 million men and 1.4 million women, or 4.6% of the Italian population. A quarter of male prevalent cases had prostate cancer (n = 305,044), while 42% of prevalent women had breast cancer (n = 604,841). More than 1.5 million people (2.7% of Italians) were alive since 5 or more years after diagnosis and 20% since ≥15 years. It is projected that, in 2020 in Italy, there will be 3.6 million prevalent cancer cases (+ 37% vs 2010). The largest 10-year increases are foreseen for prostate (+ 85%) and for thyroid cancers (+ 79%), and for long-term survivors diagnosed since 20 or more years (+ 45%). Among the population aged ≥75 years, 22% will have had a previous cancer diagnosis. Conclusions The number of persons living after a cancer diagnosis is estimated to rise of approximately 3% per year in Italy. The availability of detailed estimates and projections of the complete prevalence are intended to help the implementation of guidelines aimed to enhance the long-term follow-up of cancer survivors and to contribute their rehabilitation needs.

Published
2018

Catalog

Books, media, physical & digital resources
See catalog results